Linked Life Data

17371782

Source:http://linkedlifedata.com/resource/pubmed/id/17371782

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2007-6-21
pubmed:abstractText
The aim of the study was to evaluate the long-term cost-effectiveness of high-dose atorvastatin when compared with generic simvastatin for secondary prevention in Denmark, Finland, Norway, and Sweden based on the recently completed IDEAL trial.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0195-668X
pubmed:author
pubmed:issnType
Print
pubmed:volume
28
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1448-53
pubmed:dateRevised
2008-1-15
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
Cost-effectiveness of high-dose atorvastatin compared with regular dose simvastatin.
pubmed:affiliation
European Health Economics, Vasagatan 38, 111 20 Stockholm, Sweden. peter.lindgren@healtheconomics.se
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't